Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug 24:18:1088-1099.
doi: 10.3762/bjoc.18.111. eCollection 2022.

Scope of tetrazolo[1,5- a]quinoxalines in CuAAC reactions for the synthesis of triazoloquinoxalines, imidazoloquinoxalines, and rhenium complexes thereof

Affiliations

Scope of tetrazolo[1,5- a]quinoxalines in CuAAC reactions for the synthesis of triazoloquinoxalines, imidazoloquinoxalines, and rhenium complexes thereof

Laura Holzhauer et al. Beilstein J Org Chem. .

Abstract

The conversion of tetrazolo[1,5-a]quinoxalines to 1,2,3-triazoloquinoxalines and triazoloimidazoquinoxalines under typical conditions of a CuAAC reaction has been investigated. Derivatives of the novel compound class of triazoloimidazoquinoxalines (TIQ) and rhenium(I) triazoloquinoxaline complexes as well as a new TIQ rhenium complex were synthesized. As a result, a small 1,2,3-triazoloquinoxaline library was obtained and the method could be expanded towards 4-substituted tetrazoloquinoxalines. The compatibility of various aliphatic and aromatic alkynes towards the reaction was investigated and the denitrogenative annulation towards imidazoloquinoxalines could be observed as a competing reaction depending on the alkyne concentration and the substitutions at the quinoxaline.

Keywords: CuAAC; click reaction; denitrogenative annulation; imidazole; metal complexes; quinoxaline; tetrazole; triazole.

PubMed Disclaimer

Figures

Scheme 1
Scheme 1
Reactions of tetrazoloquinoxalines 1 to 1,2,3-triazoloquinoxalines 3 via CuAAC and denitrogenative annulation to imidazo[1,2-a]quinoxalines 2 catalyzed by an iron porphyrin catalyst 5 in combination with Zn. The scheme includes all quinoxaline-based derivatives that were obtained by these procedures so far [–12].
Scheme 2
Scheme 2
Synthesis of tetrazolo[1,5-a]quinoxalines. Reaction conditions: (a) 9, THF or 4 M HCl, 70110 °C, 2–3 h; (b) POCl3, 100 °C, 24 h, yields over two steps are given above; (c) NaN3, DMF, 6080 °C, 226 h; (d) H2NNHH2O, EtOH, 25 °C, 21 h; (e) NaNO2, AcOH/H2O, 0 °C, 3 h; (f) diverse conditions, see Supporting Information File 1 for details.
Scheme 3
Scheme 3
Synthesis of 1,2,3-triazole-substituted quinoxalines via CuAAC from tetrazolo[1,5-a]quinoxaline (11a). aSynthesis of 14j* from 14j = Et2NH, K2CO3, DMF, 70 °C, 1 d.
Scheme 4
Scheme 4
Mechanism of CuAAC vs denitrogenative annulation.
Scheme 5
Scheme 5
Synthesis of bis(tetrazolo)[1,5-a:5',1'-c]quinoxaline (24) and conversion to triazoloimidazoquinoxalines (TIQs): 2.5 equiv hexyne, 10 mol % (CuOTf)2·C6H6 (7), toluene, 100 °C, 4 h to 3 d. ORTEP diagram of triazoloimidazoquinoxaline 25b with the thermal ellipsoids shown at 50% probability.
Scheme 6
Scheme 6
Synthesis of rhenium tricarbonyl complexes 27a–d and ORTEP diagrams of the resulting molecular structures with the thermal ellipsoids shown at 50% probability.
Scheme 7
Scheme 7
Synthesis of rhenium tricarbonyl complex 29 and ORTEP diagram of the resulting molecular structure with the thermal ellipsoids shown at 50% probability.
Scheme 8
Scheme 8
Synthesis of a TIQ rhenium complex and ORTEP diagram of the obtained product 30 with the thermal ellipsoids shown at 50% probability.
Figure 1
Figure 1
UV–vis absorption spectra of the obtained metal complexes (18 µM solutions) in acetonitrile at 20 °C.
Figure 2
Figure 2
Cyclic voltammetry traces for rhenium complexes 27ad, 29 and 30: 0.5 mM in MeCN solution with 0.1 M Bu4NPF6 under nitrogen at 25 °C, recorded at 0.1 V/s at a glassy carbon electrode and referenced to the saturated calomel electrode (SCE) using Fc/Fc+ as an internal standard (0.46 V vs SCE [12]).

References

    1. Gedefaw D, Prosa M, Bolognesi M, Seri M, Andersson M R. Adv Energy Mater. 2017;7:1700575. doi: 10.1002/aenm.201700575. - DOI
    1. Xia R, Guo T, He J, Chen M, Su S, Jiang S, Tang X, Chen Y, Xue W. Monatsh Chem. 2019;150:1325–1334. doi: 10.1007/s00706-019-02449-9. - DOI
    1. Ajani O O, Obafemi C A, Nwinyi O C, Akinpelu D A. Bioorg Med Chem. 2010;18:214–221. doi: 10.1016/j.bmc.2009.10.064. - DOI - PubMed
    1. Patel S B, Patel B D, Pannecouque C, Bhatt H G. Eur J Med Chem. 2016;117:230–240. doi: 10.1016/j.ejmech.2016.04.019. - DOI - PubMed
    1. Chen Q, Bryant V C, Lopez H, Kelly D L, Luo X, Natarajan A. Bioorg Med Chem Lett. 2011;21:1929–1932. doi: 10.1016/j.bmcl.2011.02.055. - DOI - PMC - PubMed

LinkOut - more resources